Kvika Asset Management

PLAIO is an AI-powered platform designed specifically for the pharmaceutical industry. It optimizes supply chain management by replacing outdated planning methods with advanced AI, machine learning, and real-time data analytics. PLAIO enhances decision-making, improves forecast accuracy, and streamlines planning workflows through seamless integration into existing ERP systems.

EpiEndo Pharmaceuticals is a clinical-stage biopharmaceutical company focused on inflammatory disorders by strengthening epithelial barrier integrity, a key factor in the progression of diseases affecting the skin, lungs, intestinal tract, and genital tract. It develops proprietary, orally available macrolide drug candidates with potential as first-in-class, disease-modifying therapies for chronic respiratory diseases and other significant unmet medical needs. Its lead candidate, EP395, aims to be the first oral, non-antibiotic macrolide that reinforces barrier function and provides anti-inflammatory effects for COPD and related inflammatory airway conditions.